Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194234 | SCV000246847 | uncertain significance | not specified | 2015-03-09 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000668046 | SCV000792589 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000668046 | SCV001419972 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2021-09-16 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with arginine at codon 797 of the CAPN3 protein (p.His797Arg). The histidine residue is weakly conserved and there is a small physicochemical difference between histidine and arginine. This variant is present in population databases (rs766630908, ExAC 0.08%). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 210562). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000668046 | SCV002085564 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2020-09-21 | no assertion criteria provided | clinical testing |